Bridging Intestinal Failure With Teduglutide - a Case Report
Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT04916665
Collaborator
(none)
1
1
12
0.1
Study Details
Study Description
Brief Summary
In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Study Design
Study Type:
Observational
Actual Enrollment
:
1 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Bridging Intestinal Failure With Teduglutide - a Case Report
Actual Study Start Date
:
Jan 1, 2019
Actual Primary Completion Date
:
Dec 31, 2019
Actual Study Completion Date
:
Dec 31, 2019
Outcome Measures
Primary Outcome Measures
- enteral autonomy (complete discontinuation of parenteral support) [6 months]
observe if enteral autonomy may be achieved before reconstruction
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Male
Inclusion Criteria:
short bowel syndrome
Exclusion Criteria:
- <18 years
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Medical University of Vienna | Vienna | Austria |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Felix Harpain,
Principle Investigator, M.D.,
Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT04916665
Other Study ID Numbers:
- 8745632
First Posted:
Jun 7, 2021
Last Update Posted:
Jun 7, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: